Recent Articles from GlobeNewswire

LOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Atara Biotherapeutics, Inc. (“Atara” or “the Company”) (NASDAQ: ATRA) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

April same-store sales increased 3.9% year-over-year 

Transfer of Sono Motors to Its Management Team Marks Full Completion of the Strategic Transition Announced in March 2026; Sono Group Currently Operates as a Focused Digital Asset Treasury Company

GIG HARBOR, Wash., May 08, 2026 (GLOBE NEWSWIRE) -- IP Strategy Holdings, Inc. (Nasdaq: IPST) (the “Company” or “IP Strategy”) today highlighted the early access launch of Numo, a consumer application developed by Poseidon designed to scale the collection of real-world, rights-cleared training data for AI systems.

May 8, 2026

Issued on behalf of Starfighters Space, Inc.

- First U.S. pivotal study for Alpha Tau to have completed enrollment, representing a critical milestone on the path towards potential FDA pre-market approval (PMA); Company has already initiated PMA modular application process -

Inflation Reaccelerated in April; Gen Z Hit Hardest, Absorbing 6-Point Higher Price Growth vs. U.S. Average Since January 2018

XRP POWER today officially launched its next-generation AI-driven intelligent trading workspace, designed to provide users with a unified quantitative environment that integrates strategy research, market analysis, and portfolio management, driving the trading process towards a more systematic and structured direction.

NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Dan Schulman, CEO of Verizon (NYSE, Nasdaq: VZ), is scheduled to speak at the MoffettNathanson Media, Internet & Communications Conference on Wednesday, May 13, at 9:00 a.m. ET.

DOVER, USA, May 08, 2026 (GLOBE NEWSWIRE) -- E-Power Inc. (“E-Power”, the “Company”, “we” or “our”) (NASDAQ: EPOW), a leading provider of AI Data Center (AIDC) microgrid solutions and advanced battery materials, is pleased to announce that its subsidiary, Sunrise (Guizhou) New Energy Materials Co., Ltd. ("Sunrise New Energy"), has been selected as a recipient of the 2026 provincial budget for capital construction investment. The Guizhou Provincial Development and Reform Commission officially issued the notice for the first batch of investment plans, awarding a $294,000 special fund to support the "Guizhou Carbon-Based Anode Material Industrial Technology Engineering Center Innovation Capability Construction Project".

Use a beginner-friendly AI Trading Bot to participate in Bitcoin, Dogecoin, and stock markets through AI algorithms, quantitative trading models, and a fully managed automated execution system designed to capture crypto and stock trading opportunities around the clock.

New CMP release introduces MCP support, more contextual role-based access, custom day-two actions, and expanded resource handlers for organizations diversifying hybrid cloud and virtualization strategies

Positive topline Phase 1 data for BGE-102, demonstrating potential best-in-class reductions among oral NLRP3 inhibitors in inflammatory biomarkers of cardiovascular risk

NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Randian Capital, a retail activist investment firm, and a shareholder of Snap Inc. publishes Open Letter to Snap Board, calling for the Snap Board to consider evaluating strategic alternatives for the company.

Stockholders to Receive $5.80 Per Share in Cash

        

OCALA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech, Inc. (NYSEAM:AIM) (“AIM ImmunoTech” or the “Company”), a late-stage biotechnology company focused on the discovery and development of drugs for the treatment of cancer, today announced an agreement between the Company and certain accredited investors to exercise certain outstanding Class A, Class B, Class C, Class D, Class E and Class F Warrants (the “Existing Warrants”) to purchase up to an aggregate of 8,719,928 shares of common stock at a reduced exercise price of $0.48 per share for gross proceeds of approximately $4.2 million, before deducting placement agent fees and other estimated offering expenses. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.

Center addresses the needs of the modern workforce with an immersive, hands-on educational experience

DALLAS, May 08, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today reported financial results for the first quarter ended March 31, 2026, and provided business updates.

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), the parent company of IM8, the premium health and longevity brand co-founded with David Beckham, today announced it will release financial results for the first quarter 2026 ended March 31, 2026 before market open on Thursday, May 14, 2026. The Company will also hold its earnings conference call the same day at 10:00 a.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts.

AUSTIN, Texas, May 08, 2026 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Service Robotics Growth Accelerates as Global Demand Fuels Strategic Expansion,” featuring Nightfood Holdings Inc. (NGTF).

Quincy, MA, May 08, 2026 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today announced that it will host a conference call at 10:00 A.M. Eastern Time on Wednesday, May 13, 2026, to discuss the Company’s financial results for the first quarter of 2026 ended March 31, 2026, as well as the Company’s corporate progress and other developments.

Jena, Germany, May 08, 2026 (GLOBE NEWSWIRE) --  InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, announced today that it has completed its underwritten offering of 75,000,000 ordinary shares of the Company at an offering price of $2.00 per ordinary share. The aggregate gross proceeds from the offering were $150 million, before deducting the underwriting discount and offering expenses.

- Data from Phase 1b/2 trial of evorpacept + zanidatamab presented at ESMO Breast Cancer 2026 showed all patients with confirmed HER2-positive disease and high CD47 expression experienced durable responses to this combination -

Once Complete, Kratos’ Arc Jet and Laser Facility’s Multi-Domain Test Capability is Expected to Accelerate Hypersonic Materials Development for Decades, Advancing U.S. Defense Infrastructure

FREMONT, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in Precision Proteomics dedicated to enabling the earliest detection of disease, today reported financial results for the quarter ended March 31, 2026.

The aircraft will still be used in service by the state until the completion of the sale

Events plan to highlight BolaWrap®, WrapReality™, and WRAP’s integrated approach to tools, training, and policy for modern public safety, leading with compliance through sight, sound, and then sensation

BRISBANE, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards on May 4, 2026 to ten new employees under Pacira’s Amended and Restated 2014 Inducement Plan (the “Inducement Plan”) as a material inducement to each employee’s entry into employment with the company. In accordance with Nasdaq Listing Rule 5635(c)(4), the awards were approved by the People & Compensation Committee of the Board of Directors (the “Committee”) without stockholder approval.

Fayetteville, Ark., May 08, 2026 (GLOBE NEWSWIRE) -- Acres.com, the complete AI land intelligence platform, today announced the launch of Acres Intelligence, the first AI agent designed to work alongside land acquisition and development teams, to research new sites, analyze constraints, and produce professional-grade reports and dashboards in minutes, all within the platform.

BUKIT MERTAJAM, MALAYSIA, May 08, 2026 (GLOBE NEWSWIRE) -- CCH Holdings Ltd (Nasdaq: CCHH) (“CCH” or the “Company”), a Malaysia-based specialty hotpot restaurant chain, today announced that all conditions to the implementation of its dual-class share structure and redesignation of ordinary shares as Class A ordinary shares have been satisfied and that its dual-class share structure is effective on the Nasdaq Capital Market following the results of the Annual General Meeting on March 4, 2026.

STOCKHOLM, May 08, 2026 (GLOBE NEWSWIRE) -- The Ethical AI Governance Group (EAIGG) today announced a major global expansion, anchored by the launch of its European platform, the appointment of new regional leadership, and the formation of founding partnerships across industry and academia.

TORONTO, May 08, 2026 (GLOBE NEWSWIRE) -- Altus Group Limited (ʺAltus Group”, “Altus” or “the Company”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, today announced key appointments to its Canadian leadership in support of the Company’s long-term growth strategy in the Canadian market.

Recognition follows the introduction of 16 commodity futures benchmarks and growing activity across Abaxx Exchange markets

NEWTOWN, Pa., May 08, 2026 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory viral diseases, today announced plans to advance potential clinical candidates for the treatment of hantavirus infections.

Listing reflects EPHI’s commitment through the United Nations Global Major Groups and Stakeholders Forum

Live today at XOCash.com, XO Cash is a stablecoin for AI agents; its SDK lets users grant any agent its own wallet, funded from their Exodus Pay balance, while keeping the keys

PONTE VEDRA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the first quarter ended March 31, 2026.

The platform connects AI market analysis, quantitative strategy selection, bot-assisted execution, and activity tracking in one trading environment.

First Quarter Revenue Reaches $35.0 MillionExchange Service Revenue Up 45% YoYManaged Service Revenue Up 7% YoY

Development timeline on track at WULF Compute

NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- AMC Global Media Inc. ("AMC Global Media" or the "Company") (NASDAQ: AMCX) today reported financial results for the first quarter ended March 31, 2026.

EL MONTE, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced that Larry Wu, its Founder and Chief Executive Officer, will present at the 21st Annual Needham Technology, Media, & Consumer Conference on Thursday, May 14, 2026, at 2:15 p.m. ET/11:15 a.m. PT.

DALLAS, May 08, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today announced that it has closed its previously announced public offering of 2,777,778 shares of its common stock. The shares of common stock were sold to the public at a price of $3.60 per share. All of the shares of common stock sold in the public offering were sold by Hyperion DeFi. The gross proceeds to Hyperion DeFi from the offering, before deducting the underwriting discounts and commissions and other offering expenses, were approximately $10.0 million. Hyperion DeFi has also granted the sole underwriter a 30-day option to purchase up to an additional 416,666 shares of its common stock at the public offering price per share, less underwriting discounts and commissions.

Enrollment proceeding in KOMODO-1 first-in-human clinical trial of BBI-940

Regeneron also earns spot on Dow Jones Best-in-Class North America Index for six consecutive years

SAN FRANCISCO and BOSTON, May 08, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT) today announced that members of its management team will participate in the following investor conferences:

ATLANTA, May 08, 2026 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a global software and data company, today announced the Company’s management team will participate in the following upcoming investor conferences:

SAN DIEGO, May 08, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with debilitating autoimmune diseases, today announced the pricing of an underwritten offering of 23,871,526 shares of its common stock at a price of $11.52 per share and, in lieu of shares of common stock to certain investors, pre-funded warrants to purchase 2,170,138 shares of common stock at a purchase price of $11.5199 per share, which equals the offering price per share of the common stock less the $0.0001 exercise price per share of each pre-funded warrant. All the shares of common stock and pre-funded warrants in the offering are being sold by Artiva.

BROOKFIELD, NEWS, May 08, 2026 (GLOBE NEWSWIRE) -- Brookfield Business Corporation (NYSE, TSX: BBUC) announced today financial results for the quarter ended March 31, 2026.

Fundraised $21 Billion in the First Quarter; $67 Billion Year-to-Date

Initial AlloNK® (AB-101) clinical data demonstrated 71% ACR50 response in refractory rheumatoid arthritis (RA) patients with at least six months of follow-up in the company-sponsored Phase 2a basket trial, with no patients relapsing or requiring new immunomodulatory agents

Initial clinical data demonstrated 71% ACR50 response in refractory rheumatoid arthritis (RA) patients with at least six months of follow-up in the company-sponsored Phase 2a basket trial, with no patients relapsing or requiring new immunomodulatory agents

Same Center Sales Increase 1% and Reaffirms Fiscal Year 2026 Outlook

SOUTH BEND, Ind., May 08, 2026 (GLOBE NEWSWIRE) -- Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) (the “Company”) today announced that its Board of Directors declared a cash dividend on its common stock in the amount of $0.17 per share (the “Dividend”). The Dividend will be payable in cash on June 30, 2026, to stockholders of record as of the close of business on June 16, 2026.

Seoul, Korea , May 08, 2026 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games based in South Korea, today announced its unaudited financial results for the first quarter ended March 31, 2026, prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board and business updates.

Earnings Call Scheduled for 8:00 a.m. ET on May 20, 2026

BERKELEY, CA, May 08, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a  digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual’s biochemistry, announced that, by letter dated May 6, 2026, the Nasdaq Hearings Panel granted the Company’s request to transfer the listing of its securities from The Nasdaq Global Market to The Nasdaq Capital Market. The Company’s continued listing on Nasdaq is subject to the Company’s satisfaction of certain interim milestones and, ultimately, the Company’s compliance with the bid price and stockholders’ equity requirements for continued listing on the Capital Market tier by July 6, 2026.

FREMONT, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Dmitry Shubov Consulting is releasing a strategic briefing to help Southeast Asian (SEA) startups navigate the emerging “Digital Border” created by a global shift toward sovereignty-focused AI deployments. Per Gartner’s 2026 outlook, which projects that 35% of nations will be locked into region-specific AI platforms by 2027, the briefing provides a roadmap for SEA founders to adapt their product and governance practices to meet the evolving trust and compliance expectations of U.S. buyers and investors.

BEIJING, May 08, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced that it will report its unaudited consolidated results for the first quarter ended March 31, 2026, before the U.S. market opens on Wednesday, May 20, 2026.

ZUG, Switzerland, May 08, 2026 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (“HAE”) and acquired angioedema due to C1 inhibitor deficiency (“AAE-C1INH”), announced today the pricing of an underwritten offering of 3,874,664 of its ordinary shares at a price of $29.68 per share. All shares in the offering are to be sold by Pharvaris. In addition, Pharvaris has granted the underwriters a 30-day option to purchase up to an additional 581,199 ordinary shares at the public offering price, less underwriting discounts and commissions. The gross proceeds to Pharvaris from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $115 million, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about May 11, 2026, subject to satisfaction of customary closing conditions.

SOUTH BEND, Ind., May 08, 2026 (GLOBE NEWSWIRE) -- Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) (the “Company”) reported today its operating results for the quarter ended March 31, 2026.

Transaction in Own Shares   

FREUDENSTADT, Germany, May 08, 2026 (GLOBE NEWSWIRE) -- SCHMID Group N.V. (NASDAQ: SHMD) (the “Company” or “SCHMID”), a global leader in advanced manufacturing solutions for the electronics and semiconductor industries, today announced that it will host an investor conference call and webcast to discuss its annual financial results and business update.

Stellantis And Leapmotor Announce Their Intention To Take Their Strategic Partnership To The Next LevelBuilding on the success of its investment in Leapmotor and of its Stellantis-led Leapmotor International (“LPMI”) joint venture, Stellantis and Leapmotor today announce their intention to expand their strategic partnership, aimed at:

The shares in Norsk Hydro ASA will be traded ex-dividend of NOK 3.0 as from today, May 8, 2026.

VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB: DMGGF) (FRANKFURT: 6AX) ("DMG" or the "Company"), a vertically integrated blockchain and data center technology company, today announces April operational results.

SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 35,000,000 shares of LifeStance’s common stock, par value $0.01 per share (the “Common Stock”) at a public offering price of $8.15 per share, pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”) from certain stockholders of the Company (the “Selling Stockholders”). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive any proceeds from the offering.

AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI) (“Mobia Medical”), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced the pricing of its initial public offering of 10,000,000 shares of its common stock at a public offering price of $15.00 per share. All of the shares of common stock are being offered by Mobia. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and other offering expenses payable by Mobia Medical, are expected to be approximately $150.0 million, excluding any exercise of the underwriters’ option to purchase additional shares. Mobia Medical’s common stock is expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “MOBI” on May 8, 2026. The offering is expected to close on May 11, 2026, subject to the satisfaction of customary closing conditions. In addition, Mobia Medical has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions.

LOS ANGELES, May 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sanara MedTech Inc. (“Sanara” or “the Company”) (NASDAQ: SMTI) for violations of the securities laws.

VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- Equinox Gold Corp. (TSX: EQX, NYSE American: EQX) (“Equinox Gold” or the “Company”) is pleased to announce detailed voting results from the Company’s Annual Meeting of Shareholders held on May 7, 2026.

BOSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (“Odyssey”), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that are designed to precisely target disease pathology, today announced the pricing of its upsized initial public offering of 15,500,000 shares of its common stock at an initial public offering price of $18.00 per share. In addition, Odyssey has granted the underwriters a 30-day option to purchase up to an additional 2,325,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions.

BEIJING, May 07, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the Investigational New Drug (IND) by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) to conduct a Phase II clinical trial of its novel TYK2 inhibitor ICP-488 for the treatment of Sjögren's syndrome.